Antimicrobial Resistance in Nigeria’s Healthcare System: Use, Challenges & Stewardship

Antimicrobial Resistance in Nigeria’s Healthcare System

Nigeria’s public health system continues to evolve as new diseases emerge, but one rising threat demands urgent attention Antimicrobial resistance in Nigeria. As hospitals, laboratories, and policymakers work to strengthen early detection and proper antibiotic use, the fight against resistant infections has become central to protecting communities and improving treatment outcomes nationwide.

The country’s healthcare leaders, supported by scientific organizations and community initiatives, are now investing in surveillance, awareness, and responsible drug-use practices to ensure safer healthcare for all Nigerians.

Antimicrobial resistance in Nigeria’s healthcare system

Antimicrobial resistance in Nigeria’s healthcare system has become a significant concern as infections that were once easily treated now require stronger or multiple medications. Hospitals frequently report cases where patients do not respond to routine antibiotics, highlighting gaps in diagnosis, drug misuse, and treatment monitoring.

Across the country, health experts are working to develop stronger systems that track resistant infections, improve laboratory accuracy, and support clinicians in making evidence-based decisions. As antimicrobial resistance in Nigeria’s healthcare system continues to grow, the focus has shifted to early detection, community education, and more controlled access to prescription drugs.

These efforts ensure that patients receive the right treatment at the right time, helping reduce complications and limit the spread of resistant pathogens.

Antimicrobial Use and Resistance in Nigeria

Understanding Antimicrobial Use and Resistance in Nigeria is essential for improving treatment outcomes and reducing avoidable deaths. In many communities, antibiotics are still purchased without prescriptions, leading to widespread misuse and self-medication. This directly contributes to treatment failures and accelerates resistance in common infections.

To address this, health institutions and national stakeholders are creating awareness programs, strengthening pharmacy regulations, and guiding clinicians toward standardized treatment protocols. By monitoring consumption trends, experts can identify inappropriate drug use and develop strategies that support rational prescribing practices.

As Antimicrobial Use and Resistance in Nigeria continues to shape public health policies, data-driven decisions and continuous community engagement are becoming key components of long-term AMR control.

Strengthening Antimicrobial Stewardship in Nigeria

Strengthening Antimicrobial Stewardship in Nigeria is now one of the most important ways to prevent resistance and protect vulnerable populations. Stewardship programs help doctors and pharmacists understand when antibiotics are necessary and when they are not ensuring that treatments remain effective for future generations.

Hospitals are implementing stewardship committees, training health workers, and reviewing prescriptions to ensure appropriate drug selection, dosage, and duration. These structured programs help reduce unnecessary antibiotic use and promote safer clinical practices.

Community-level action is equally important. Through awareness campaigns and health education, the message is clear: antibiotics should be used responsibly. As Strengthening Antimicrobial Stewardship in Nigeria continues to expand, both healthcare workers and the public are learning how proper drug use supports a healthier nation.

Challenges and the Path Forward

Nigeria faces notable challenges in tackling antimicrobial resistance, including limited laboratory capacity, insufficient public awareness, and inconsistent regulation of antibiotic sales. Misinformation also plays a significant role, as many people still believe antibiotics cure every illness including viral infections.

However, the path forward is promising. Investments in health infrastructure, improved surveillance systems, and stronger partnerships with global health organizations are equipping Nigeria with the tools needed to reduce AMR risks. Collaborative efforts between government, healthcare professionals, and community groups are creating a more resilient, informed, and prepared healthcare system.

Scroll to Top
akinsete-omobosola-1004-240x240-29843

Dr. Omobosola Akinsete is a dedicated physician and a key member of the Nigerian Antimicrobial Stewardship Taskforce. She has been an internal medicine and adult Infectious Disease physician in the United States of America for 30  years . She graduated from Medical school at the University of Lagos, and has a masters in Public Health from Johns Hopkins school of Public Health. 

She did her Internal Medicine training at a Brown University hospital and her fellowship in Infectious Diseases  at the University of Minnesota where she is an associate professor. She has worked with the National Institutes of Health and Howard University a a coordinator for the Human Genome Project among other projects, she is a frequent public speaker and contributor to different types of media. She loves to advocate for healthcare in minority populations. She  has a lot of experience with  patients and health care providers on antimicrobial stewardship in her institution  HealthPartners in Minnesota U.S.A. Her expertise in the field of Infectious diseases and antimicrobial stewardship and her passion to improve health care in her home country will contribute significantly to the fight against antimicrobial resistance in Nigeria. Dr. Akinsete’s work with the taskforce focuses on leadership of the taskforce as chairperson and national coordinator, working closely with NCDC leadership, the Nigerian Federal Ministry of Health, stakeholders, and funding partners, and helping with capacity building of standardized antimicrobial stewardship and infectious disease educational programs. She will also use her expertise to guide providers and HealthCare institutions  on the ground . Her commitment to improving antimicrobial use and patient safety is invaluable to the nation’s public health efforts.